Last reviewed · How we verify

NCT06178796

Bone-Implant Contact Surface Influence on Dental Implant Stability

Completed NA Last updated 19 September 2024
What this trial tests

NA trial testing Dental implant in Missing Teeth in 30 participants. Completed in 1 February 2024.

Timeline
1 October 2022
Primary endpoint
1 January 2024
1 February 2024

Quick facts

Lead sponsorMarmara University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment30
Start date1 October 2022
Primary completion1 January 2024
Estimated completion1 February 2024
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Marmara University

Who can join

Adults 18 to 65, any sex, with Missing Teeth. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate the changes in the stability and bone-implant contact surface of implants of the same macro-design placed with particle grafting in the fresh extraction socket, without grafting, and placed in healed implant sites.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Virtual bone-implant contact surface effect on implant stability in fresh extraction and healed sites: a pilot randomised clinical trial.
    Askin Ekinci S, Fettahzade S, Gocmen G, Bayram F, et al · · 2026 · PMID 41974820 · DOI 10.1038/s41598-026-48697-8

Verify or expand the search:

Other trials of Dental implant

Trials testing the same drug.

Other recruiting trials for Missing Teeth

Currently open trials in the same condition.

Other Marmara University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06178796.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing